Trade Summary

3 days ago, Anders Jack, serving as Chief Financial Officer at Revolution Medicines, Inc. (RVMD), sold 2,722 shares at $156.12 per share, for a total transaction value of $424,956.46. Following this transaction, Anders Jack now holds 123,269 shares of RVMD.

This sale represents a 2.16% decrease in Anders Jack's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, June 16, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 at 4:10 PM ET, 2 days after the trade was made.

Revolution Medicines, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.